The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
Cancer Med
; 9(10): 3390-3399, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32187452
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Adenine
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Protein Kinase Inhibitors
/
Deprescriptions
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos